D-33 30 [hp_X]/mL
ATROPA BELLADONNA, BUFO BUFO CUTANEOUS GLAND, COPPER, ANEMONE PRATENSIS, SILICON DIOXIDE, and ZINC · SOLUTION · DNA Labs, Inc.
D-33 is a solution containing atropa belladonna, bufo bufo cutaneous gland, copper, anemone pratensis, silicon dioxide, and zinc at 30 [hp_X]/mL, taken sublingual. Manufactured by DNA Labs, Inc..
Key Facts
- Brand Name
- D-33
- Generic Name
- ATROPA BELLADONNA, BUFO BUFO CUTANEOUS GLAND, COPPER, ANEMONE PRATENSIS, SILICON DIOXIDE, and ZINC
- NDC Code (Product)
58264-0033- Manufacturer
- DNA Labs, Inc.
- Strength
- 30 [hp_X]/mL
- Dosage Form
- SOLUTION
- Route
- SUBLINGUAL
- Marketing Status
- Drug Class
- Copper-containing Intrauterine Device [EPC]
- Marketing Start
- 01/01/1990
Recall History
No Recall HistoryFrequently Asked Questions
What is D-33 used for?
D-33 contains ATROPA BELLADONNA, BUFO BUFO CUTANEOUS GLAND, COPPER, ANEMONE PRATENSIS, SILICON DIOXIDE, and ZINC. It is a solution taken sublingual. Consult your doctor for specific uses.
Is D-33 a controlled substance?
D-33 is not classified as a controlled substance by the DEA.
What is the generic name for D-33?
The generic name for D-33 is ATROPA BELLADONNA, BUFO BUFO CUTANEOUS GLAND, COPPER, ANEMONE PRATENSIS, SILICON DIOXIDE, and ZINC. There are no other listed brand versions of ATROPA BELLADONNA, BUFO BUFO CUTANEOUS GLAND, COPPER, ANEMONE PRATENSIS, SILICON DIOXIDE, and ZINC.
What is the NDC code for D-33 30 [hp_X]/mL?
The NDC (National Drug Code) for D-33 30 [hp_X]/mL is 58264-0033, listed by DNA Labs, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)